The effect of concurrent oral administration of propranolol and disopyramide on cardiac function in healthy men.
- 1 May 1980
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 61 (5) , 938-945
- https://doi.org/10.1161/01.cir.61.5.938
Abstract
Sixteen healthy men were evaluated for left ventricular performance changes and beta-blockade after therapeutic oral doses of disopyramide and propranolol administered alone and concurrently. The volunteers were randomly assigned to receive one of two drug treatment regimens that differed in the sequence and duration of administration of the drugs. Left ventricular function was assessed by echocardiographically determined ejection fraction (EF) and systolic time intervals. Beta-blockade was assessed by changes in exercise heart rate. Both disopyramide and propranolol exhibited negative inotropic activity, as evidenced by significant, although clinically inconsequential, decreases in EF and increases in the ratio of preejection period to left ventricular ejection time. The negative inotropic effects of a single 200-mg dose of disopyramide and an 80-mg dose of propranolol were comparable, while chronic disopyramide therapy (200 mg every 6 hours for 1 week) had a greater negative inotropic effect than chronic propranolol therapy (80 mg every 8 hours for 1 week). Only propranolol had beta-adrenoceptor blocking activity. When the drugs were administered concurrently, the negative inotropic effects of oral propranolol and disopyramide were neither additive nor synergistic.This publication has 12 references indexed in Scilit:
- ORAL DISOPYRAMIDE FOR THE PREVENTION OF ARRHYTHMIAS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ADMITTED TO OPEN WARDSThe Lancet, 1977
- Pharmacokinetics of propranolol in normal healthy volunteersJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Hemodynamic and Electrocardiographic Effects of Disopyramide in Patients with Ventricular ArrhythmiaActa Medica Scandinavica, 1976
- Determination of disopyramide and its mono-N-dealkylated metabolite in blood serum and urineJournal of Chromatography A, 1975
- Haemodynamic effects of intravenous disopyramide in heart failureEuropean Journal of Clinical Pharmacology, 1975
- Disopyramide phosphate: Clinical efficacy of a new oral antiarrhythmie drugClinical Pharmacology & Therapeutics, 1974
- Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphateAmerican Heart Journal, 1972
- The comparative inotropic effects of six clinically used antiarrhythmic agentsAmerican Heart Journal, 1972
- Bedside technics for the evaluation of ventricular function in manThe American Journal of Cardiology, 1969